greeksoup/ stock research

SiriusPoint Ltd.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 18 February 2026: press release. Guidance figures: 5 new. The quarter’s numbers.

Key takeaways

  • Full-year operating earnings rose sharply: Full-year operating earnings per share rose 49% to $2.55, with net income available to common shareholders of $444 million, or $3.64 per diluted share. Operating ROE was 16.2%. Source
  • Quarter net income lifted by gains: Fourth-quarter net income available to common shareholders was $240 million, or $1.97 per diluted share, with operating EPS of $0.70. Annualized ROE was 44.9%, reflecting $222.4 million of gains on sale or deconsolidation of MGAs. Source
  • Insurance & Services drove premium growth: Insurance & Services gross written premium rose 23.5% in the quarter to $556.0 million, driven by Surety in Other Specialties, A&H growth and London MGA programs. Full-year gross written premium rose 25.7%. Source
  • Core combined ratio rose in quarter: Fourth-quarter Core combined ratio was 92.9%, up from 90.2%. Full-year Core combined ratio was 91.7%, up from 91.0%. Source
  • Prior-year reserve releases shrank: Favorable prior-year loss reserve development was $15.0 million in the quarter, versus $58.1 million a year earlier, and $72.2 million for the full year versus $100.7 million. Source
  • Book value per share grew strongly: Book value per diluted share ex. AOCI rose $1.63 in the quarter, or 9.9%, to $18.10, and rose 23.6% for the year, a $3.46 increase. Source
  • Series B preference shares to be redeemed: All 8,000,000 Series B preference shares will be redeemed February 26, 2026 at $25.00 plus $0.49 accrued dividends, simplifying the capital structure and eliminating related cash servicing cost. Source
  • Leverage to fall to record low: Post-redemption leverage ratio is expected at 23%, with pro-forma BSCR of 232% compared with a year-end estimate of 247%. Source
  • $100 million buyback planned: Management intends to repurchase $100 million of common shares over the next 12 months, after a $483.0 million share repurchase liability at year-end 2024 that is no longer present. Source
  • Arcadian stake sale to Lee Equity: The 49% Arcadian stake was sold to Lee Equity Partners for $140.4 million including a pre-close dividend, closing January 30, 2026. Capacity agreement renewed to 2031; pre-tax gain of about $25.0 million expected in Q1 2026. Source

“The fourth quarter rounded out another very strong year for SiriusPoint.”

Scott Egan, Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Share repurchases Sourcenext 12 months$100 million of common sharesNew
Leverage ratio Sourceafter Series B preference share redemption23%New
BSCR ratio Sourcepro-forma after Series B redemption232%New
Arcadian gain Sourcefirst quarter of 2026approximately $25.0 million pre-tax gainNew
Assist America consideration Sourceacquisition$42.5 millionNew

What changed from last quarter

  • New: Agreed sale of 49% stake in Arcadian to Lee Equity Partners for $140.4 million including pre-close dividend; closed January 30, 2026, with capacity agreement renewed to 2031. Source
  • New: Agreed to acquire Assist America, a global emergency travel assistance provider; control effective January 1, 2026, consolidated from Q1 2026. Source
  • New: Announced redemption of all 8,000,000 Series B preference shares on February 26, 2026, at $25.00 plus $0.49 accrued dividends, with plans to delist and deregister. Source
  • New: Entered agreement to purchase the World Nomads travel insurance business from nib Travel Pty Ltd., with a staged closing. Source
  • Ended: Deconsolidated ArmadaCorp Capital, LLC effective November 1, 2025 upon its sale to Ambac Financial Group; capacity partnership continues to end of 2030. Source
  • New: Share repurchase of $100 million over the next 12 months announced; prior period showed a $483.0 million share repurchase liability at December 31, 2024. Source

Results and growth drivers

  • Full-year operating earnings rose sharply: Full-year operating earnings per share rose 49% to $2.55, with net income available to common shareholders of $444 million, or $3.64 per diluted share. Operating ROE was 16.2%. Source
  • Quarter net income lifted by gains: Fourth-quarter net income available to common shareholders was $240 million, or $1.97 per diluted share, with operating EPS of $0.70. Annualized ROE was 44.9%, reflecting $222.4 million of gains on sale or deconsolidation of MGAs. Source
  • Premium growth across lines: Full-year gross written premium rose 16% and net written premium rose 19%. Fourth-quarter gross and net written premium each grew 18%. Source
  • Underwriting income increased for year: Consolidated underwriting income was $302.8 million for the year, up from $276.4 million, driven by premium growth and an improved attritional loss ratio, partly offset by lower favorable prior-year development and higher catastrophe losses. Source

Segments and regions

  • Insurance & Services drove premium growth: Insurance & Services gross written premium rose 23.5% in the quarter to $556.0 million, driven by Surety in Other Specialties, A&H growth and London MGA programs. Full-year gross written premium rose 25.7%. Source
  • Reinsurance premium growth modest: Reinsurance gross written premium rose 9.2% in the quarter to $340.9 million, led by London and New York Casualty, partly offset by Bermuda Property rate decreases and London Specialty. Source
  • Reinsurance underwriting income higher in quarter: Reinsurance underwriting income was $22.1 million at a 92.1% combined ratio, up from $18.3 million, as catastrophe losses fell $30.7 million, partly offset by lower favorable prior-year development. Source
  • Insurance & Services income fell in quarter: Insurance & Services segment income was $30.7 million versus $48.4 million, mainly from lower favorable prior-year development ($10.4 million versus $16.3 million) and acquisition cost true-up. Source

“Against this backdrop we are delighted to announce that over the next 12 months, we intend to repurchase $100 million of common shares.”

Scott Egan, Chief Executive Officer

Products and customers

  • Surety expansion and A&H growth: Premium growth was attributed to expansion of Surety within Other Specialties, growth across Accident & Health, and organic and new program growth in international business, including London MGAs. Source
  • Service fee income shifted with Armada: Net services income fell to $4.2 million from $10.4 million, mainly from deconsolidating Armada, partly offset by higher fee income from International Medical Group. Source

Costs, margins and loss development

  • Core combined ratio rose in quarter: Fourth-quarter Core combined ratio was 92.9%, up from 90.2%. Full-year Core combined ratio was 91.7%, up from 91.0%. Source
  • Catastrophe losses lower in quarter: Fourth-quarter catastrophe losses were $7.0 million, or 1.0 point on the combined ratio, versus $38.6 million, or 6.6 points, a year earlier. Full-year catastrophe losses were $74.4 million, mainly California wildfires. Source
  • Prior-year reserve releases shrank: Favorable prior-year loss reserve development was $15.0 million in the quarter, versus $58.1 million a year earlier, and $72.2 million for the full year versus $100.7 million. Source
  • Attritional loss ratio improved for year: Full-year attritional loss ratio improved, with the Core attritional ratio at 59.0%, and management cited improved attritional loss ratio as a driver of underwriting income growth. Source

Investments and returns

  • Investment income lower on smaller asset base: Debt securities and short-term investment income for the year was $264.6 million, down from $289.7 million, due to a smaller asset base following 2024 and early 2025 capital transactions. Source
  • Book value per share grew strongly: Book value per diluted share ex. AOCI rose $1.63 in the quarter, or 9.9%, to $18.10, and rose 23.6% for the year, a $3.46 increase. Source

Capital, cash and shareholder returns

  • Series B preference shares to be redeemed: All 8,000,000 Series B preference shares will be redeemed February 26, 2026 at $25.00 plus $0.49 accrued dividends, simplifying the capital structure and eliminating related cash servicing cost. Source
  • Leverage to fall to record low: Post-redemption leverage ratio is expected at 23%, with pro-forma BSCR of 232% compared with a year-end estimate of 247%. Source
  • $100 million buyback planned: Management intends to repurchase $100 million of common shares over the next 12 months, after a $483.0 million share repurchase liability at year-end 2024 that is no longer present. Source

Strategy, deals and investment

  • Arcadian stake sale to Lee Equity: The 49% Arcadian stake was sold to Lee Equity Partners for $140.4 million including a pre-close dividend, closing January 30, 2026. Capacity agreement renewed to 2031; pre-tax gain of about $25.0 million expected in Q1 2026. Source
  • Assist America acquisition agreed: Agreement to acquire Assist America, a travel and medical assistance provider serving over 40 million members, with control effective January 1, 2026 and consolidation from Q1 2026. Source
  • World Nomads purchase in stages: Agreement signed February 12, 2026 to buy the World Nomads travel insurance business from nib; initial closing expected Q2 or Q3 2026, final closing in second half 2027, subject to regulatory approvals. Source
  • Armada sale deconsolidated: ArmadaCorp Capital was sold to Ambac Financial Group and deconsolidated effective November 1, 2025; the capacity partnership continues to 2030. Source

Management view and ambition

  • Management cites strong year: The CEO described 2025 as a very strong year, citing disciplined underwriting, a 16% top-line increase, 1.5 points of underwriting earnings quality improvement and 28% diluted book value growth. Source
  • Operating ROE above target range: Operating ROE of 16.2% for the year is described as improved for a third consecutive year and above the 12-15% across-the-cycle target. Source

Coming up, as management said on 18 February 2026

  • Series B redemption on February 26: Series B preference shares are to be redeemed on February 26, 2026, followed by planned delisting from NYSE and deregistration. Source
  • Arcadian pre-tax gain in Q1 2026: A pre-tax gain of approximately $25.0 million is to be recognized in the first quarter of 2026. Source
  • Assist America consolidation from Q1 2026: Assist America will be consolidated in the first quarter of 2026, with control effective January 1, 2026. Source
  • World Nomads initial closing: Initial closing on most of World Nomads expected in Q2 or Q3 2026; final closing expected in second half of 2027. Source

Risks management discussed

  • Financial: Series B preference share redemption and the planned $100 million repurchase affect capital structure and leverage; the press release mentions no risk items beyond prior disclosures. Source
  • Operational: Catastrophe losses and prior-year reserve development both affect underwriting results; management noted lower catastrophe losses and smaller reserve releases in the quarter. Source

Earlier plans management reported on

  • Ahead: Management states full-year operating ROE of 16.2% outperformed its 12-15% across-the-cycle target. Source
  • On track: Management said the leverage ratio will fall to 23% by the end of February 2026, following the Series B redemption. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.